Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder

J Autism Dev Disord. 2021 Dec;51(12):4370-4394. doi: 10.1007/s10803-021-05237-9. Epub 2021 Sep 7.

Abstract

Recent decades have been marked by a wave drug treatment research in autism spectrum disorder (ASD). This work has resulted in improved ability to treat commonly occurring behavioral challenges associated with ASD including most prominently irritability marked by aggression, self-injurious behavior, and severe tantrums. While treatment of interfering behavior has progressed in our field, there remain several areas of unmet medical need including most prominently a lack of any approved drug therapies for the core, defining symptoms of autism. We outline the progress to date in the field of autism drug treatment while taking a future look forward into how decades of work can inform better future steps in this field.

Keywords: Anti-psychotic; Autism; Autism spectrum disorder; Drug treatment; Irritability; Psychopharmacology.

MeSH terms

  • Antipsychotic Agents* / therapeutic use
  • Autism Spectrum Disorder* / drug therapy
  • Autistic Disorder* / drug therapy
  • Humans
  • Irritable Mood
  • Psychopharmacology*

Substances

  • Antipsychotic Agents